Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, today announced that OTC Markets Group has removed the "Caveat Emptor" designation from the ...

The design of prostheses has significantly evolved thanks to advances in biomechanics and computational simulation. Traditionally, the development of these ...